Aspirin Dosing with Ticagrelor 90 mg Twice Daily
When combining ticagrelor 90 mg twice daily with aspirin (Ecosprin), use the lower dose of 75 mg daily, not 150 mg. 1
Guideline-Based Recommendation
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines explicitly state that aspirin doses of ≤100 mg daily should always be used in patients treated with ticagrelor 1. This recommendation is based on post-hoc analysis from the PLATO trial showing an association between higher aspirin doses and worse outcomes when combined with ticagrelor.
Specific Dosing Algorithm:
For acute coronary syndrome (loading phase):
- Aspirin loading dose: 162-325 mg orally (chewed if non-enteric coated)
- Ticagrelor loading dose: 180 mg orally
For maintenance therapy:
- Aspirin: 75-100 mg daily (your choice should be 75 mg, not 150 mg)
- Ticagrelor: 90 mg twice daily
Why Not 150 mg Aspirin?
The evidence is clear that higher aspirin doses (>100 mg) with ticagrelor:
Do not provide additional efficacy - Low-dose aspirin (75-100 mg) was not inferior to higher doses for reducing major adverse cardiovascular events 1
Increase bleeding risk - Higher aspirin doses were associated with increased minor and gastrointestinal bleeding without additional benefit 1
May reduce ticagrelor's effectiveness - The PLATO trial analysis suggested potential interaction between ticagrelor and aspirin doses >100 mg, though this remains somewhat controversial 2
European Guidelines Concordance
The 2024 ESC guidelines for chronic coronary syndromes also recommend aspirin 75-100 mg daily when used with ticagrelor, reinforcing this dosing strategy across international guidelines 3.
Clinical Pitfalls to Avoid
- Don't use 150 mg aspirin with ticagrelor - This exceeds guideline recommendations and increases bleeding risk without proven benefit
- Don't confuse loading and maintenance doses - The loading dose can be higher (162-325 mg), but maintenance must be ≤100 mg
- Consider switching from 150 mg to 75 mg - If a patient is already on 150 mg aspirin, reduce to 75-100 mg when initiating ticagrelor
Supporting Research Evidence
A Chinese observational study found that 50 mg aspirin daily with ticagrelor 90 mg twice daily reduced bleeding events without increasing ischemic risk compared to 75-100 mg aspirin 4. While this suggests even lower doses may be safe, current guidelines support 75-100 mg as the evidence-based standard.
Bottom line: Use Ecosprin 75 mg daily, not 150 mg, when combining with ticagrelor 90 mg twice daily. 1